- Location
apixaban
"-
FDA Accepted to Review Bristol-Myers and Pfizer's Eliquis Supplemental New Drug
Jul 12, 2013The US FDA has accepted to review Bristol-Myers Squibb Company and Pfizer's Eliquis (apixaban) supplemental new drug application for prophylaxis of deep vein thrombosis (DVT) subsequent to hip or knee replacement surgery. The application ...
Tags: Drug Application, Medicine
-
Bristol-Myers Squibb and Pfizer Have Announced The US FDA's Approval for Eliquis
Jan 4, 2013Bristol-Myers Squibb and Pfizer have announced the US FDA's approval for Eliquis (apixaban), used to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. In 2007, Pfizer and Bristol-Myers ...
Tags: US, FDA, Eliquis, patients, nonvalvular atrial fibrillation
-
Bristol-Myers Squibb and Pfizer Announced The Approval of Eliquis
Dec 28, 2012Bristol-Myers Squibb and Pfizer have announced the approval of Eliquis (apixaban) anticoagulant for the prevention of ischemic stroke and systemic embolism in patients suffering from nonvalvular atrial fibrillation (NVAF) in Japan. The ...
Tags: Japan, approval, anticoagulant, subanalysis
-
The European Commission Has Cleared an Oral Anticoagulant, Eliquis
Nov 28, 2012The European Commission has cleared an oral anticoagulant, Eliquis, developed by Bristol-Myers Squibb (BMS) and Pfizer. Eliquis 5mg, trade name of apixaban in Europe, is indicated as a twice-daily drug for preventing strokes and systemic ...
Tags: BMS-Pfizer Oral Anticoagulant, oral anticoagulant, Eliquis, apixaban
![CAS 473927-63-8 Acetic Acid, Chloro[ (4-METHOXYPHENYL) Hydrazono]-, Ethyl Ester, (2Z)](https://image.made-in-china.com/3f2j00FwjiBdYMwEqV/CAS-473927-63-8-Acetic-Acid-Chloro-4-METHOXYPHENYL-Hydrazono-Ethyl-Ester-2Z-.jpg "CAS 473927-63-8 Acetic Acid, Chloro[ (4-METHOXYPHENYL) Hydrazono]-, Ethyl Ester, (2Z)")